CJJD China Jo-Jo Drugstores Inc.: רווח נקי למניה (EPS TTM)

The growth of China Jo-Jo Drugstores (CJJD) is fueled by China's aging population and the digitalization of pharmaceutical delivery. Analyzing the trailing twelve-month net income per share on GURU.Markets, we note that -2.33 shows the level of this metric. The business's success relies on network density and government regulation, while back-office efficiency is enhanced through the implementation of RPA bots for accounting automation.
פילוחי נתונים אנליטיים מרוכזים עבור jiuzhou-drugstore.com (CJJD)

For China Jo-Jo Drugstores (CJJD), the trend of rolling net income per share reflects real business efficiency without the influence of market noise. This metric is calculated as the ratio of total annual profit to the total number of issued shares. This indicator allows for an assessment of the fundamental return per share of the company. As the pharmacy chain adapts to Asian digital regulations, the volatility of this indicator determines the asset's degree of speculativeness. Stable EPS growth confirms the model's resilience to regulatory risks.